The direct medical cost of diabetes in the U.S. was estimated at over $300 billion in 2022, with more than 38 million ...
NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) (“NervGen” or the “Company”), a clinical-stage biopharmaceutical company ...
Oral macrocyclic peptides have the potential to offer biologic-like efficacy and safety in a convenient oral formatCollaboration further advances Biogen’s immunology strategy by broadening its early-s ...
The 2025 drill campaign was designed to infill, expand, and refine the boundaries of REE mineralization at Hecla-Kilmer, guided by updated 3D geological and geophysical models. The objective was to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results